These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32841537)
1. Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region. Tanaka Y; O'Neill S; Li M; Tsai IC; Yang YW Arthritis Care Res (Hoboken); 2022 Feb; 74(2):187-198. PubMed ID: 32841537 [TBL] [Abstract][Full Text] [Related]
2. The economic burden of systemic lupus erythematosus in Asia: the current state. Mak A Lupus; 2010 Oct; 19(12):1442-6. PubMed ID: 20947555 [TBL] [Abstract][Full Text] [Related]
3. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States. Kariburyo F; Xie L; Sah J; Li N; Lofland JH J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081 [No Abstract] [Full Text] [Related]
4. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Jakes RW; Bae SC; Louthrenoo W; Mok CC; Navarra SV; Kwon N Arthritis Care Res (Hoboken); 2012 Feb; 64(2):159-68. PubMed ID: 22052624 [TBL] [Abstract][Full Text] [Related]
5. The humanistic and economic burden of systemic lupus erythematosus : a systematic review. Meacock R; Dale N; Harrison MJ Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592 [TBL] [Abstract][Full Text] [Related]
6. Lupus Nephritis in Asia: Clinical Features and Management. Yap DY; Chan TM Kidney Dis (Basel); 2015 Sep; 1(2):100-9. PubMed ID: 27536670 [TBL] [Abstract][Full Text] [Related]
7. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study. Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of systemic lupus erythematosus: an update. Stojan G; Petri M Curr Opin Rheumatol; 2018 Mar; 30(2):144-150. PubMed ID: 29251660 [TBL] [Abstract][Full Text] [Related]
9. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort. Cann MP; Sage AM; McKinnon E; Lee SJ; Tunbridge D; Larkins NG; Murray KJ Lupus; 2022 Feb; 31(2):246-255. PubMed ID: 35037500 [TBL] [Abstract][Full Text] [Related]
10. Lupus Nephritis: A Different Disease in European Patients? Tesar V; Hruskova Z Kidney Dis (Basel); 2015 Sep; 1(2):110-8. PubMed ID: 27536671 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need. Nikpour M; Bridge JA; Richter S Intern Med J; 2014 Dec; 44(12a):1170-9. PubMed ID: 25169712 [TBL] [Abstract][Full Text] [Related]
12. Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus. Nakai T; Fukui S; Kidoguchi G; Ikeda Y; Kitada A; Nomura A; Tamaki H; Kishimoto M; Okada M Clin Rheumatol; 2022 Dec; 41(12):3735-3745. PubMed ID: 35939162 [TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687 [TBL] [Abstract][Full Text] [Related]
14. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis. Fatoye F; Gebrye T; Mbada C Rheumatol Int; 2022 Dec; 42(12):2097-2107. PubMed ID: 36006459 [TBL] [Abstract][Full Text] [Related]
15. Development of the Asia Pacific Lupus Collaboration cohort. Kandane-Rathnayake R; Golder V; Louthrenoo W; Luo SF; Jan Wu YJ; Li Z; An Y; Lateef A; Sockalingam S; Navarra SV; Zamora L; Hamijoyo L; Katsumata Y; Harigai M; Chan M; O'Neill S; Goldblatt F; Hao Y; Zhang Z; Al-Saleh J; Khamashta M; Takeuchi T; Tanaka Y; Bae SC; Lau CS; Hoi A; Nikpour M; Morand EF Int J Rheum Dis; 2019 Mar; 22(3):425-433. PubMed ID: 30398013 [TBL] [Abstract][Full Text] [Related]
16. Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017. Chiong E; Murphy DG; Akaza H; Buchan NC; Chung BH; Kanesvaran R; Khochikar M; Letran J; Lojanapiwat B; Ng CF; Ong T; Pu YS; Saad M; Schubach K; Türkeri L; Umbas R; Le Chuyen V; Williams S; Ye DW; ; Davis ID BJU Int; 2019 Jan; 123(1):22-34. PubMed ID: 30019467 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Danchenko N; Satia JA; Anthony MS Lupus; 2006; 15(5):308-18. PubMed ID: 16761508 [TBL] [Abstract][Full Text] [Related]
18. Belimumab for systemic lupus erythematosus. Singh JA; Shah NP; Mudano AS Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010668. PubMed ID: 33631841 [TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022 [TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. Miyazaki C; Sruamsiri R; Mahlich J; Jung W J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541 [No Abstract] [Full Text] [Related] [Next] [New Search]